Alveolar Ridge Augmentation Following Self-Inflating Soft Tissue Expander
NCT ID: NCT03153995
Last Updated: 2020-12-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
16 participants
INTERVENTIONAL
2017-11-01
2020-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The assessment and comparison will be based on:
1. Change in edentulous alveolar ridge in bucco-lingual dimension after alveolar
ridge augmentation.
2. Quantity of the soft tissue obtained after soft tissue expansion.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Three surgeries will be carried out for group I patient; the first is placement of soft tissue expander, the second surgery is bone grafting and placement of collagen membrane for ridge augmentation while the third (re-entry surgery) is implant placement in a routine fashion.
two surgeries will be carried out for group II patient; the first is surgery is bone grafting for ridge augmentation while the second (re-entry surgery) is implant placement in a routine fashion.
-Measurements and evaluation of edentulous ridge will be done by CBCT
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
sub-periosteal soft tissue expansion
Eight patients will receive osmotic hydrogel expanders prior to bone augmentation procedures. All expanders will be placed in sub-periosteal positions using the tunnel technique.
soft tissue expansion
Three surgeries will be carried out for group I patients:
* Soft tissue expansion (1st surgery); at baseline
* Alveolar ridge augmentation (2nd surgery); after five weeks
* Implant surgery (3rd surgery); after six months
periosteal releasing incision
periosteal releasing incision will be performed for Eight patients during ridge augmentation surgery .
soft tissue expansion
Three surgeries will be carried out for group I patients:
* Soft tissue expansion (1st surgery); at baseline
* Alveolar ridge augmentation (2nd surgery); after five weeks
* Implant surgery (3rd surgery); after six months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
soft tissue expansion
Three surgeries will be carried out for group I patients:
* Soft tissue expansion (1st surgery); at baseline
* Alveolar ridge augmentation (2nd surgery); after five weeks
* Implant surgery (3rd surgery); after six months
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All patients should not have any particular medical history (medically free) according to Burket health medical history questionnaire (Glick et al.2008).
* All patients should not have any known contraindication to oral surgery.
Exclusion Criteria
* Patients with poor oral hygiene or not willing to perform oral hygiene measures.
* Patients who showed residual infections in the edentulous area or apparent infection in a neighboring tooth.
* Patients with systemic diseases such as diabetes mellitus and hemorrhagic disorders, patients receiving intravenous bisphosphonate therapy or systemic corticosteroid treatment.
* Patients with occlusal discrepancies will be excluded.
* Vulnerable groups (as pregnant and lactating females, and decisionaly impaired individuals) will be excluded from the study.
20 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alaa Talaat Ali
assistant lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ahmed Amr, lecturer
Role: STUDY_DIRECTOR
Ainshams University
Nevine Kheir eldin, professor
Role: STUDY_DIRECTOR
Ainshams University
Ehab Abd elhamid, professor
Role: STUDY_DIRECTOR
Ainshams University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of dentistry Ain Shams university
Cairo, Cairo Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FDASU-REC per-16-3
Identifier Type: -
Identifier Source: org_study_id